by HBOT News | Mar 2, 2016 | Peripheral Neuropathy
Abstract: Worldwide, more than a million people receive each year a curative radiotherapy. While local control and overall survival are steadily increasing, 5 to 15% of patients still develop above grade 2 late toxicities. Late toxicities treatments are complex....
by HBOT News | Feb 27, 2016 | Cancer
Abstract: Bisphosphonate drugs can be used to prevent and treat osteoporosis and to reduce symptoms and complications of metastatic bone disease; however, they are associated with a rare but serious adverse event: osteonecrosis of the maxillary and mandibular bones....
by HBOT News | Feb 12, 2016 | Cancer
Abstract: Hyperbaric Oxygen Therapy (HBOT) is increasingly applied in different areas of medical practice. The oxy-hyperbarism effects are not well understood in cancer malignancy. One unique feature of cancer is the presence of hypoxic regions that are insensitive to...
by HBOT News | Feb 8, 2016 | Cancer
Abstract: Osteoradionecrosis (ORN) of the jaws is a feared complication of head and neck radiotherapy. ORN causes significant morbidity for patients and controversy among clinicians. This overview considers the variations in definition and classification of the...
by HBOT News | Feb 6, 2016 | Cancer
Abstract: To evaluate the efficacy of hyperbaric oxygen therapy (HBO) in the treatment of postradiation hematuria (PRH) and to identify the predictive factors for a successful outcome. We conducted a retrospective study and included all patients with PRH treated with...
